Bittensor (TAO): The Leading AI Token by Market Capitalization
Synaptogenix, Inc. (Nasdaq: SNPX) has announced the initiation of a unique cryptocurrency treasury strategy that will concentrate solely on the artificial intelligence (AI) token “TAO.” This token currently holds the distinction of being the most prominent AI token in terms of both market capitalization and adoption. To spearhead this initiative, the company has enlisted the expertise of James Altucher, a recognized figure in both cryptocurrency and AI realms, who will be responsible for developing strategies aimed at generating revenue through staking yields and increasing the value of the token.
The company plans to initially invest $10 million in TAO tokens, which is more than double its existing market valuation. Furthermore, Synaptogenix has set an ambitious goal of acquiring a total of $100 million in TAO tokens moving forward. This initial purchase will be made possible through the company’s substantial cash reserves and robust financial standing.
Chairman of the Board, Joshua Silverman, remarked, “Towards the end of 2024, our Board of Directors began examining various avenues to create value by effectively utilizing our significant cash reserves. We have observed a steady trend of public and private companies successfully integrating digital assets into their corporate treasuries or business strategies. We believe that TAO, as the leading AI token, presents the most promising potential for growth and adoption, thereby offering an excellent opportunity to enhance and safeguard value for our shareholders. We are privileged to have James Altucher on board, a global expert in both AI and crypto, to lead our revenue generation and staking strategies aimed at significantly boosting shareholder value.”
In his assessment, Silverman noted, “Our preliminary analysis suggests that the fixed supply of 21 million TAO tokens combined with the surging global demand for AI innovation makes TAO an attractive cryptocurrency.” Mr. Altucher, an accomplished entrepreneur and venture capitalist, brings decades of experience in new technologies, including AI and cryptocurrency. He was an early advocate for Bitcoin and even established the first “Bitcoin-only” retail store. His extensive contributions to the field include numerous scholarly articles on AI and presentations at esteemed AI conferences.
“The AI sector is projected to expand tenfold by 2030, and a portion of all investments in AI is anticipated to flow towards decentralized AI, where TAO stands out as the frontrunner. I am thrilled to join what I see as the only pure public company that focuses on the intersection of cryptocurrency and AI, both of which are poised for exponential growth,” stated Altucher.
TAO serves as the native token for Bittensor, a decentralized blockchain network dedicated to machine learning and AI. Bittensor aims to democratize AI development by providing an open-access environment for the creation, training, and evaluation of AI models. Participants, including miners and validators, are incentivized based on their contributions’ value, as assessed through information theory principles such as novelty, relevance, or efficiency in shared AI knowledge. Rewards for these contributions are distributed in TAO tokens.
To align with its digital asset treasury strategy centered on the AI token TAO, Synaptogenix plans to rebrand itself, which will include a name change and a new ticker symbol. A revamped corporate website is also in the works, with further details expected to be revealed in the coming months.
Additionally, Synaptogenix has disclosed that it has entered into securities purchase agreements for a financing deal worth $5.5 million, which involves James Altucher in the sale of 5,500 shares of its newly issued Series D convertible preferred stock. Each share has a stated value of $1,000 and is convertible into common stock in a private placement, along with five-year warrants for common stock purchases. This financing agreement is scheduled to be finalized on or around June 10, 2025, pending the fulfillment of standard closing conditions. The Series D preferred stock carries a conversion price of $3.00 per share, and the warrants have an exercise price of $3.00 per common share. Further details regarding the financing, consulting contracts with Mr. Altucher, and management changes have been outlined in the current report on Form 8-K filed with the SEC earlier today.
Forward-Looking Statements
This press release from Synaptogenix may contain forward-looking statements, which are not historical facts and are subject to various risks and uncertainties. These factors could cause actual outcomes and the timing of events to differ significantly from those projected in the forward-looking statements. Such risks and uncertainties are documented in the company’s filings with the Securities and Exchange Commission, and the company does not commit to updating any forward-looking statements.
